(Sharecast News) - Novartis raised its full-year earnings guidance on Tuesday after reporting higher third-quarter core operating profit, driven by strong sales of its key medicines and improved margins.
The Swiss pharmaceutical group said net sales rose 4% to $14.5bn in the three months to 30 September, while core operating income...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE